Livongo to Present at Upcoming Investor Conferences
On September 8, 2020, Livongo Health (Nasdaq: LVGO) announced upcoming presentations at investor conferences regarding their merger with Teladoc Health.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
On September 8, 2020, Livongo Health (Nasdaq: LVGO) announced upcoming presentations at investor conferences regarding their merger with Teladoc Health. Key events include the Wells Fargo Securities Healthcare Conference on September 10 at 8:00 a.m. ET and the Morgan Stanley 18th Annual Global Healthcare Conference on September 16 at 9:30 a.m. ET. Livongo focuses on empowering individuals with chronic conditions through its AI-driven health solutions, improving health outcomes and experiences. Archives of the webcasts will be available on Livongo's Investor Relations site.
Details
News Market Reaction – LVGO
The recorded move for LVGO in the trading session of this news was -2.68%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MOUNTAIN VIEW, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company, together with executives from Teladoc Health, will be presenting at the following upcoming investor conferences and discussing their pending merger:
- Wells Fargo Securities Healthcare Conference on Thursday, September 10 at 8:00 a.m. Eastern Time
- Morgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16 at 9:30 a.m. Eastern Time
A live webcast of each presentation, as well as archived recordings, will be available on the Investor Relations section of the company’s website, https://www.livongo.com/.
About Livongo
Livongo empowers people with chronic conditions to live better and healthier lives, beginning with diabetes and now including hypertension, weight management, diabetes prevention, and behavioral health. Livongo pioneered the category of Applied Health Signals to offer Members clinically-based insights that focus on the whole person and make it easier to stay healthy. Using its AI+AI engine, Livongo's team of data scientists aggregate and interpret substantial amounts of health data and information to create actionable, personalized, and timely health signals delivered to Livongo Members exactly when and where they need them. The Livongo approach delivers better clinical and financial outcomes while creating a different and better experience for people with chronic conditions. For more information, visit: www.livongo.com or engage with Livongo on LinkedIn or Twitter.
Investor Contact:
Jason Plagman
Investor-relations@livongo.com
785-550-6048
Media Contact:
John Hallock
Press@livongo.com
617-615-7712
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.